Journal
Frontiers in Molecular Neuroscience
Publication Date
1-1-2023
Volume
16
First Page
1320182
Document Type
Open Access Publication
DOI
10.3389/fnmol.2023.1320182
Rights and Permissions
Vemula P, Schoch KM and Miller TM (2023) Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo. Front. Mol. Neurosci. 16:1320182. doi: 10.3389/fnmol.2023.1320182 © 2023 Vemula, Schoch and Miller. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Vemula, Pranav; Schoch, Kathleen M; and Miller, Timothy M, "Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo." Frontiers in Molecular Neuroscience. 16, 1320182 (2023).
https://digitalcommons.wustl.edu/oa_4/3862
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
